Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8YBG
DownloadVisualize
BU of 8ybg by Molmil
Crystal structure of lysozyme by serial synchrotron crystallography
Descriptor: CHLORIDE ION, Lysozyme C, SODIUM ION
Authors:Nam, K.H.
Deposit date:2024-02-14
Release date:2024-02-28
Method:X-RAY DIFFRACTION (1.55 Å)
Cite:Crystal structure of lysozyme by serial synchrotron crystallography
To Be Published
8S0M
DownloadVisualize
BU of 8s0m by Molmil
Crystal structure of the HKU1 receptor binding domain in complex with TMPRSS2 and the nanobody A01
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanobody A01, ...
Authors:Duquerroy, S, Fernandez, I, Rey, F.
Deposit date:2024-02-14
Release date:2024-06-26
Method:X-RAY DIFFRACTION (3.55 Å)
Cite:Structural insights into TMPRSS2 maturation and HKU1 binding
To Be Published
8S0L
DownloadVisualize
BU of 8s0l by Molmil
Crystal structure of the TMPRSS2 zymogen in complex with the nanobody A07
Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, CALCIUM ION, Nanobody A07, ...
Authors:Duquerroy, S, Fernandez, I, Rey, F.
Deposit date:2024-02-14
Release date:2024-06-26
Method:X-RAY DIFFRACTION (1.8 Å)
Cite:Structural insights into TMPRSS2 maturation and HKU1 binding
To Be Published
8S0N
DownloadVisualize
BU of 8s0n by Molmil
Crystal structure of the TMPRSS2 zymogen in complex with the nanobody A07
Descriptor: Transmembrane protease serine 2, nanobody A07
Authors:Duquerroy, S, Fernandez, I, Rey, F.
Deposit date:2024-02-14
Release date:2024-06-26
Method:X-RAY DIFFRACTION (2.3 Å)
Cite:Structural insights into TMPRSS2 maturation and HKU1 binding
To Be Published
8S0P
DownloadVisualize
BU of 8s0p by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 1-[3-[2,3-bis(chloranyl)phenyl]-1H-pyrrolo[3,2-b]pyridin-6-yl]-4-methyl-piperidin-4-amine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (2 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S0K
DownloadVisualize
BU of 8s0k by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 3-[2,3-bis(chloranyl)phenyl]-5-methyl-6-(piperazin-1-ylmethyl)-1H-pyrrolo[3,2-b]pyridine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.84 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S0S
DownloadVisualize
BU of 8s0s by Molmil
A fragment-based inhibitor of SHP2
Descriptor: (1R,5S)-8-[7-(4-chloranyl-2-methyl-indazol-5-yl)-5H-pyrrolo[2,3-b]pyrazin-3-yl]-8-azabicyclo[3.2.1]octan-3-amine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.94 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S0O
DownloadVisualize
BU of 8s0o by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 3-[4-chloranyl-2-(1H-pyrazol-4-ylmethyl)indazol-5-yl]-5-methyl-6-(piperazin-1-ylmethyl)-1H-pyrrolo[3,2-b]pyridine, FORMIC ACID, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.834 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S0I
DownloadVisualize
BU of 8s0i by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 3-phenyl-1H-pyrrolo[3,2-b]pyridine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.929 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S0Q
DownloadVisualize
BU of 8s0q by Molmil
A fragment-based inhibitor of SHP2
Descriptor: (1S,5R)-8-[3-[2,3-bis(chloranyl)phenyl]-1H-pyrrolo[3,2-b]pyridin-6-yl]-8-azabicyclo[3.2.1]octan-3-amine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.872 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S0H
DownloadVisualize
BU of 8s0h by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 5-(aminomethyl)-N-(3-chloranyl-1-methyl-indol-7-yl)-1,3-dihydroisoindole-2-sulfonamide, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.99 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S0J
DownloadVisualize
BU of 8s0j by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 3-[3-[2,3-bis(chloranyl)phenyl]-1H-pyrrolo[3,2-b]pyridin-6-yl]propan-1-amine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-14
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.89 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8W00
DownloadVisualize
BU of 8w00 by Molmil
Q108K:K40L:T51V:T53S:Y19W:R58W:L117E mutant of hCRBPII bound to synthetic fluorophore TD-1V
Descriptor: (2E)-3-{5-[4-(dimethylamino)phenyl]thiophen-2-yl}but-2-enal, ACETATE ION, Retinol-binding protein 2
Authors:Nossoni, Z, Bingham, C.R, Geiger, J.H.
Deposit date:2024-02-13
Release date:2024-04-03
Method:X-RAY DIFFRACTION (1.23 Å)
Cite:Regulation of Emission via a Protein-Bound Fluorophore
To Be Published
8VZZ
DownloadVisualize
BU of 8vzz by Molmil
Q108K:K40L:T51V:T53S:Y19W:R58W mutant of hCRBPII bound to synthetic fluorophore TD-1V
Descriptor: (2E)-3-{5-[4-(dimethylamino)phenyl]thiophen-2-yl}but-2-enal, ACETATE ION, Retinol-binding protein 2
Authors:Nosssoni, Z, Bingham, C.R, Geiger, J.H, Borhan, B.
Deposit date:2024-02-13
Release date:2024-04-03
Method:X-RAY DIFFRACTION (1.22 Å)
Cite:Regulation of Emission via a Protein-Bound Fluorophore
To Be Published
8VZY
DownloadVisualize
BU of 8vzy by Molmil
Q108K:K40L:T51V:T53S:R58Y mutant of hCRBPII bound to synthetic fluorophore TD-1V
Descriptor: (2E)-3-{5-[4-(dimethylamino)phenyl]thiophen-2-yl}but-2-enal, ACETATE ION, Retinol-binding protein 2
Authors:Nossoni, Z, Bingham, C.R, Geiger, J.H, Borhan, B.
Deposit date:2024-02-13
Release date:2024-04-03
Method:X-RAY DIFFRACTION (1.34 Å)
Cite:Regulation of Emission via a Protein-Bound Fluorophore
To Be Published
8W02
DownloadVisualize
BU of 8w02 by Molmil
Q108K:K40L:T51V:T53S:R58W mutant of hCRBPII bound to synthetic fluorophore TD-1V
Descriptor: (2E)-3-{5-[4-(dimethylamino)phenyl]thiophen-2-yl}but-2-enal, ACETATE ION, Retinol-binding protein 2
Authors:Ghanbarpour, A, Geiger, J.H, Borhan, B.
Deposit date:2024-02-13
Release date:2024-04-03
Method:X-RAY DIFFRACTION (1.499 Å)
Cite:Regulation of Emission via a Protein-Bound Fluorophore
To Be Published
8VZX
DownloadVisualize
BU of 8vzx by Molmil
Q108K:K40L:T53A:R58F mutant of hCRBPII bound to synthetic fluorophore TD-1V
Descriptor: (2E)-3-{5-[4-(dimethylamino)phenyl]thiophen-2-yl}but-2-enal, ACETATE ION, Retinol-binding protein 2
Authors:Nossoni, Z, Bingham, C.R, Geiger, J.H.
Deposit date:2024-02-13
Release date:2024-04-03
Method:X-RAY DIFFRACTION (1.47 Å)
Cite:Regulation of Emission via a Protein-Bound Fluorophore
To Be Published
8RZW
DownloadVisualize
BU of 8rzw by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 3,5-bis(chloranyl)pyrazin-2-amine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-13
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (2.02 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S06
DownloadVisualize
BU of 8s06 by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 1H-pyrrolo[3,2-b]pyridin-7-amine, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-13
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (2.19 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S04
DownloadVisualize
BU of 8s04 by Molmil
A fragment-based inhibitor of SHP2
Descriptor: N-(1H-indol-7-yl)methanesulfonamide, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-13
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.89 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8RZV
DownloadVisualize
BU of 8rzv by Molmil
Structure of UP1 S4ES6E phosphomimetic mutant in complex with human telomeric repeat DNA
Descriptor: DNA (5'-D(P*TP*AP*GP*GP*GP*TP*TP*AP*GP*GP*G)-3'), Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed
Authors:Dunnett, L, Prischi, F.
Deposit date:2024-02-13
Release date:2024-03-13
Method:X-RAY DIFFRACTION (1.51 Å)
Cite:Structure of UP1 S4ES6E phosphomimetic mutant in complex with human telomeric repeat DNA
To Be Published
8S01
DownloadVisualize
BU of 8s01 by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 3-(4-chlorophenyl)-1H-pyrazole, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-13
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (2.17 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8S07
DownloadVisualize
BU of 8s07 by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 7-azanyl-N-pyridin-3-yl-3H-pyrrolo[3,2-b]pyridine-2-carboxamide, DIMETHYL SULFOXIDE, FORMIC ACID, ...
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-13
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.83 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8RZY
DownloadVisualize
BU of 8rzy by Molmil
A fragment-based inhibitor of SHP2
Descriptor: 1H-pyrrolo[3,2-b]pyridin-5-amine, DIMETHYL SULFOXIDE, Tyrosine-protein phosphatase non-receptor type 11
Authors:Cleasby, A, Price, A.
Deposit date:2024-02-13
Release date:2024-03-20
Last modified:2024-04-10
Method:X-RAY DIFFRACTION (1.91 Å)
Cite:Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2).
J.Med.Chem., 67, 2024
8VZ7
DownloadVisualize
BU of 8vz7 by Molmil
Crystal Structure of Human Cytochrome P450 2C9*27 (R150L) Genetic Variant in Complex with the Drug Losartan
Descriptor: Cytochrome P450 2C9, POTASSIUM ION, PROTOPORPHYRIN IX CONTAINING FE, ...
Authors:Shah, M.B.
Deposit date:2024-02-11
Release date:2024-06-12
Last modified:2024-06-26
Method:X-RAY DIFFRACTION (2.53 Å)
Cite:Structural and biophysical analysis of cytochrome P450 2C9*14 and *27 variants in complex with losartan.
J.Inorg.Biochem., 258, 2024

222624

건을2024-07-17부터공개중

PDB statisticsPDBj update infoContact PDBjnumon